EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Magnetic Hyperthermia Therapy for High-Grade Glioma: A State-of-the-Art Review

Benjamin Rodriguez iD, Daniel Rivera, Jack Y Zhang, Cole Brown iD, Tirone Young, Tyree Williams iD, Sakibul Huq, Milena Mattioli, Alexandros Bouras, Constantinos G Hadjpanayis

Pharmaceuticals · 26.02.2024 · 17 (3) · 300

DOI: 10.3390/ph17030300 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 26.02.2024. Verfasst von Benjamin Rodriguez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Magnetic hyperthermia therapy (MHT) is a re-emerging treatment modality for brain tumors where magnetic nanoparticles (MNPs) are locally delivered to the brain and then activated with an external alternating magnetic field (AMF) to generate localized heat at a site of interest. Due to the recent advancements in technology and theory surrounding the intervention, clinical and pre-clinical trials have demonstrated that MHT may enhance the effectiveness of chemotherapy and radiation therapy (RT) for the treatment of brain tumors. The future clinical success of MHT relies heavily on designing MNPs optimized for both heating and imaging, developing reliable methods for the local delivery of MNPs, and designing AMF systems with integrated magnetic particle imaging (MPI) for use in humans. However, despite the progression of technological development, the clinical progress of MHT has been underwhelming. This review aims to summarize the current state-of-the-art of MHT and offers insight into the current barriers and potential solutions for moving MHT forward.

Schlagwörter

Stichwörter der Autor:innen

HGG = High Grade GliomaMHT: Magnetic Hyperthermia TherapyMNP = Magnetic Nanoparticlegliomahyperthermia

Autor:innen und Institutionen

  • Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Sinai BioDesign, Department of Neurosurgery, Mount Sinai, New York, NY 10029, USA.
  • Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
  • Department of Neurological Surgery, UPMC, Pittsburgh, PA 15213, USA.
  • Brain Tumor Nanotechnology Laboratory, UPMC Hillman Cancer Center, Pittsburgh, PA 15213, USA.
  • Center for Image-Guided Neurosurgery, Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.

ORCID-Profile: Benjamin Rodriguez, Cole Brown, Tyree Williams

Zitieren

APA

Rodriguez, B., Rivera, D., Zhang, J. Y., Brown, C., Young, T., Williams, T., Huq, S., Mattioli, M., Bouras, A., & Hadjpanayis, C. G. (2024). Magnetic Hyperthermia Therapy for High-Grade Glioma: A State-of-the-Art Review. Pharmaceuticals, 17(3), 300. https://doi.org/10.3390/ph17030300

Vancouver

Rodriguez B, Rivera D, Zhang JY, Brown C, Young T, Williams T, et al. Magnetic Hyperthermia Therapy for High-Grade Glioma: A State-of-the-Art Review. Pharmaceuticals. 2024;17(3):300. doi:10.3390/ph17030300

BibTeX
@article{Rodriguez2024,
  author = {Rodriguez, Benjamin and Rivera, Daniel and Zhang, Jack Y and Brown, Cole and Young, Tirone and Williams, Tyree and Huq, Sakibul and Mattioli, Milena and Bouras, Alexandros and Hadjpanayis, Constantinos G},
  title = {Magnetic Hyperthermia Therapy for High-Grade Glioma: A State-of-the-Art Review},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {3},
  pages = {300},
  doi = {10.3390/ph17030300}
}
Kostenlos starten →